President's Message

Dear CIS Members:

At this point I hope that we are all recovered from what was another successful Spring season of meetings and conferences. One of those being the 2022 CIS Annual Meeting! I would once again like to extend a thank you to the 777 attendees (both in person -532- and virtual -245-), the 2022 Program Committee, and specifically our Co-Chairs, Drs. Elie Haddad and Rebecca Marsh who made everything possible during our full week of science.

As I’m sure you saw in your emails this week, CIS would like you to consider sending Congress a message to keep the VALID (Verifying Accurate Leading-edge IVCT Development) Act out of MDUFA (Medical Device User Fee Agreement), ensuring that clinical laboratories can continue to provide LDT (Laboratory Developed Tests) to our PID/IEI patients. This will only take a few minutes of your time, and can be completed at this link.

Along that same vein, the CIS Thymic Defect Taskforce has resurrected to address the current issue that patients and physicians face regarding the cost and waiting list of thymic transplants. While we all know the severity and scope of this problem, data must be collected to provide overall direction and support to actions that may incur in the future to take care of this issue.

Finally, let me take this opportunity to announce some changes in the CIS staff. After almost two years as the Executive Director of CIS, Nadine Couto has moved to a different position within the EDI management company and will be transitioning to another team. Nadine has done an incredible job during these past two years! Her efficiency, leadership and wisdom serve as examples of excellence in management. On behalf of the CIS leadership and Council I would like to express my gratitude to Nadine and the EDI team for their dedication to our society over the years.

While we are saddened to lose Nadine, I am pleased to welcome our new Executive Director, Justin Dodge, who has been with EDI since 2015, and has had experience working with many clients. We are very much looking forward to working with him for many years to come!

Please stay tuned for coming details regarding the 2023 Annual Meeting in St. Louis!


Sergio Rosenzweig, MD, PhD
CIS President 2021-2023, on behalf of the Clinical Immunology Society